Fu Liwan, Wang Yuquan, Hu Yue-Qing
Center for Non-Communicable Disease Management, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China.
State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute, Institute of Biostatistics, Fudan University, Shanghai, China.
Front Nutr. 2023 Mar 6;10:1015046. doi: 10.3389/fnut.2023.1015046. eCollection 2023.
Many observational studies evaluate the association between vitamin B12 and non-alcoholic fatty liver disease (NAFLD). However, the causality of this association remains uncertain, especially in European populations. We conducted a bidirectional Mendelian randomization study to explore the association between vitamin B12 and NAFLD.
Two-sample Mendelian randomization study was conducted. Summary statistics for vitamin B12 were acquired from a genome-wide association studies (GWAS) meta-analysis including 45,576 subjects. Summary-level data for NAFLD was obtained from a GWAS meta-analysis of 8,434 cases and 770,180 non-cases and another GWAS meta-analysis of 1,483 cases and 17,781 non-cases. Summary-level data for 4 enzymes including alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma glutamyltransferase (GGT), was available from the UK Biobank. Inverse variance weighting (as main analysis), weighted median estimate, robust adjusted profile score, MR-Egger, and MR-PRESSO (sensitivity analyses) were performed to calculate causal estimates.
Genetically predicted higher vitamin B12 concentrations were consistently associated with an increased NAFLD in two sources. The combined odds ratio (OR) of NAFLD was 1.30 (95% confidence interval (CI), 1.13 to 1.48; < 0.001) per SD-increase in vitamin B12 concentrations. Genetic liability to NAFLD was also positively associated with vitamin B12 concentrations (Beta 0.08, 95%CI, 0.01 to 0.16; = 0.034). Sensitivity analyses also revealed consistent results. Genetically predicted vitamin B12 concentrations showed no significant association with liver enzymes.
The present study indicates that increased serum vitamin B12 concentrations may play a role in NAFLD risk. NAFLD also has a causal impact on elevated vitamin B12 concentrations in the circulation. Notably, vitamin B12 concentrations imply the levels of vitamin B12 in the circulation, and higher intake of vitamin B12 may not directly lead to higher levels of serum vitamin B12, instead the higher levels of vitamin B12 in the circulation may be caused by the dysregulation of the metabolism of this vitamin in this study. There exist bidirectional causal effects between serum vitamin B12 concentrations and risk of NAFLD in European individuals.
许多观察性研究评估了维生素B12与非酒精性脂肪性肝病(NAFLD)之间的关联。然而,这种关联的因果关系仍不确定,尤其是在欧洲人群中。我们进行了一项双向孟德尔随机化研究,以探讨维生素B12与NAFLD之间的关联。
进行了两样本孟德尔随机化研究。维生素B12的汇总统计数据来自一项包括45576名受试者的全基因组关联研究(GWAS)荟萃分析。NAFLD的汇总水平数据来自一项对8434例病例和770180例非病例的GWAS荟萃分析,以及另一项对1483例病例和17781例非病例的GWAS荟萃分析。包括碱性磷酸酶(ALP)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和γ-谷氨酰转移酶(GGT)在内的4种酶的汇总水平数据可从英国生物银行获得。采用逆方差加权法(作为主要分析方法)、加权中位数估计法、稳健调整轮廓得分法、MR-Egger法和MR-PRESSO法(敏感性分析)来计算因果估计值。
在两个数据源中,基因预测的较高维生素B12浓度始终与NAFLD增加相关。维生素B12浓度每增加1个标准差,NAFLD的合并比值比(OR)为1.30(95%置信区间(CI),1.13至1.48;P<0.001)。NAFLD的遗传易感性也与维生素B12浓度呈正相关(β=0.08,95%CI,0.01至0.16;P=0.034)。敏感性分析也得出了一致的结果。基因预测的维生素B12浓度与肝酶无显著关联。
本研究表明,血清维生素B12浓度升高可能在NAFLD风险中起作用。NAFLD对循环中维生素B12浓度升高也有因果影响。值得注意的是,维生素B12浓度反映的是循环中的维生素B12水平,较高的维生素B12摄入量可能不会直接导致血清维生素B12水平升高,相反,本研究中循环中较高的维生素B12水平可能是由该维生素代谢失调引起的。在欧洲个体中,血清维生素B12浓度与NAFLD风险之间存在双向因果效应。